Wagner, Anna S.
Semmlack, Saskia
Frei, Anja
Rüegg, Stephan http://orcid.org/0000-0002-5836-622X
Marsch, Stephan http://orcid.org/0000-0002-4095-2765
Sutter, Raoul http://orcid.org/0000-0002-6575-356X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Seizures and risks for recurrence in critically ill patients: an observational cohort study
https://doi.org/10.1007/s00415-022-11038-6
Funding for this research was provided by:
University of Basel
Article History
Received: 14 December 2021
Revised: 9 February 2022
Accepted: 16 February 2022
First Online: 2 March 2022
Declarations
:
: Anna S. Wagner reports no disclosures. Saskia Semmlack reports no disclosures. Anja Frei reports no disclosures. Stephan Rüegg received unconditional research grants from UCB-pharma. He received honoraria from serving on the scientific advisory boards of Arvelle, Eisai, and UCB-pharma, and from serving as a consultant for Arvelle, Eisai, Pfizer, Novartis, Sandoz, and UCB-pharma. He does not hold any stocks of any pharmaceutical industries or manufacturers of medical devices. He received funding from UCB-pharma, and Swiss National Science Foundation Grants: Grant Number 320030_169379/1 and coapplicant for grants numbers 33CM30_125115/1 and 33CM30_140338/1; he disclosed that he is the past-president of the Swiss League against Epilepsy (no payments), editor of EPILEPTOLOGIE (Journal of the Swiss League against Epilepsy) (no payments), and editor of the Swiss EEG Bulletin (payments from UCB); Stephan Marsch reports no disclosures. Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal Grants from UCB-pharma and holds stocks from Novartis, Roche, Alcon, and Johnson & Johnson.
: Prior to the initiation of the study the Swiss ethics committee (Ethikkommission Norwest- und Zentralschweiz approval number 2018-02361) approved the study concept in compliance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments and waived patients’ consent.
: Not applicable.